ACHIEVE LIFE SCIENCES, INC. Quarterly Costs and Expenses in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Achieve Life Sciences, Inc. quarterly/annual Costs and Expenses history and growth rate from Q2 2010 to Q2 2024.
  • Achieve Life Sciences, Inc. Costs and Expenses for the quarter ending June 30, 2024 was $8.43M, a 9.3% increase year-over-year.
  • Achieve Life Sciences, Inc. Costs and Expenses for the twelve months ending June 30, 2024 was $25.4M, a 36.2% decline year-over-year.
  • Achieve Life Sciences, Inc. annual Costs and Expenses for 2023 was $27.3M, a 33.2% decline from 2022.
  • Achieve Life Sciences, Inc. annual Costs and Expenses for 2022 was $40.8M, a 23.3% increase from 2021.
  • Achieve Life Sciences, Inc. annual Costs and Expenses for 2021 was $33.1M, a 124% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $25.4M $8.43M +$717K +9.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $24.7M $5.98M -$2.6M -30.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $27.3M $4.39M -$6.48M -59.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $33.7M $6.57M -$6.07M -48% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $39.8M $7.71M -$2.36M -23.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 $42.2M $8.58M +$1.35M +18.7% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $40.8M $10.9M +$3.75M +52.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $37.1M $12.6M +$5.95M +88.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $31.1M $10.1M -$1.23M -10.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $32.3M $7.23M -$758K -9.49% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $33.1M $7.12M +$2.39M +50.7% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-10
Q3 2021 $30.7M $6.69M +$2.94M +78.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $27.8M $11.3M +$8.38M +287% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $19.4M $7.98M +$4.63M +138% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $14.8M $4.72M +$1.51M +47.1% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 $13.2M $3.75M +$37K +1% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-10
Q2 2020 $13.2M $2.92M -$744K -20.3% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-10
Q1 2020 $13.9M $3.36M -$2.58M -43.5% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-10
Q4 2019 $16.5M $3.21M -$500K -13.5% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-11
Q3 2019 $17M $3.72M +$423K +12.8% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-11
Q2 2019 $16.6M $3.66M +$866K +31% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-11
Q1 2019 $15.7M $5.94M +$2.93M +97.1% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-11
Q4 2018 $12.8M $3.71M -$73K -1.93% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-13
Q3 2018 $12.9M $3.29M +$923K +38.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-03-13
Q2 2018 $12M $2.8M +$2.64M +1670% Apr 1, 2018 Jun 30, 2018 10-K 2020-03-13
Q1 2018 $9.33M $3.01M +$2.69M +839% Jan 1, 2018 Mar 31, 2018 10-K 2020-03-13
Q4 2017 $6.63M $3.78M +$3.17M +521% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-14
Q3 2017 $3.46M $2.37M +$1.97M +496% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-14
Q2 2017 $1.49M $158K -$195K -55.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-14
Q1 2017 $1.68M $321K -$33K -9.32% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-14
Q4 2016 $1.71M $609K -$8.89M -93.6% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 $10.6M $398K -$11M -96.5% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 $21.6M $353K -$9.26M -96.3% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 $30.9M $354K -$6.02M -94.4% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 $36.9M $9.5M -$2.82M -22.9% Oct 1, 2015 Dec 31, 2015 10-K 2017-02-23
Q3 2015 $39.7M $11.4M -$617K -5.12% Jul 1, 2015 Sep 30, 2015 10-K 2017-02-23
Q2 2015 $40.3M $9.61M -$2.95M -23.5% Apr 1, 2015 Jun 30, 2015 10-K 2017-02-23
Q1 2015 $43.3M $6.37M -$13.3M -67.6% Jan 1, 2015 Mar 31, 2015 10-K 2017-02-23
Q4 2014 $56.6M $12.3M -$3.32M -21.2% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-09
Q3 2014 $59.9M $12M -$8.43M -41.2% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-09
Q2 2014 $68.3M $12.6M -$3.18M -20.2% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-09
Q1 2014 $71.5M $19.7M +$6.31M +47.2% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-09
Q4 2013 $65.2M $15.6M -$389K -2.43% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-26
Q3 2013 $65.6M $20.5M +$5.62M +37.8% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-26
Q2 2013 $60M $15.7M +$7.36M +87.9% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-26
Q1 2013 $52.6M $13.4M +$6.54M +95.9% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-26
Q4 2012 $46.1M $16M +$6.82M +74.1% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-11
Q3 2012 $39.3M $14.9M +$9.59M +182% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-11
Q2 2012 $29.7M $8.37M +$1.49M +21.7% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-11
Q1 2012 $28.2M $6.82M +$395K +6.15% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-11
Q4 2011 $27.8M $9.21M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-07
Q3 2011 $5.27M -$6.56M -55.4% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-07
Q2 2011 $6.88M +$2.33M +51.1% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-07
Q1 2011 $6.42M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-07
Q3 2010 $11.8M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-03
Q2 2010 $4.55M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.